Jiangsu Jland Biotech in Jingjiang, Jiangsu province, received the province's first cross provincial approval for the review of medical device advertisements in the Yangtze River Delta region on Feb 27.
"We submitted an application online just once and received approval documents covering three provinces and one city within two to three days, demonstrating significantly improved efficiency," said Chang Liang, the company's chairman.
An exhibition area in Jiangsu Jland Biotech. [Photo/WeChat account: jingjiangfabu]
Previously, if a medical device advertisement contained multiple products and the corresponding manufacturing enterprises were based in different provinces, the advertising applicant needed to submit separate applications to the advertising review authorities of the relevant provinces.
In January of this year, the State Administration for Market Regulation agreed to launch a pilot program for the cross-regional review of medical device advertisements in the Yangtze River Delta region, helping reduce costs for advertising applicants.
The company is an original equipment manufacturer (OEM) and original design manufacturer (ODM) comprehensive service provider for freeze-drying products and recombinant collagen skincare products. It boasts advanced freeze-drying equipment and freeze-drying technology processes, and its products are primarily marketed in the Yangtze River Delta region.
The pilot program is expected to shorten the promotion cycle for individual products by 30 percent, boosting the company's market competitiveness.